News
Guska, Scaffold Biotech, and Eolo Pharma Recognized by the Nova Award
Guska, Scaffold Biotech, and Eolo Pharma were selected among the ten stories honored in the 10th edition of the Nova Award, organized by Uruguay’s National Agency for Research and Innovation (ANII). Over its previous nine editions, NOVA has recognized high-impact projects from startups, companies, public and private institutions, foundations, and...
Pilot Plant Under Construction to Produce Scaffold Biotech’s Vaccine
Work is being finalized on a pilot GMP plant where Scaffold Biotech will produce batches of its vaccine against bovine ticks. The plant is located next to the startup’s laboratory within the Institut Pasteur de Montevideo. Its inauguration is planned for October, and work is underway to obtain the necessary authorization. The vaccines produced...
Scaffold Biotech Presents Its Vaccine to the Chinese Embassy
Scaffold Biotech, which is developing a vaccine against bovine ticks, presented its work to the Chinese Ambassador to Uruguay, Huang Yazhon, and Counselor Jiang Minghui. The officials visited the Institut Pasteur de Montevideo, where they met with the institute’s leadership and members of the startup. Ticks are a challenge affecting several...
Read the second edition of our newsletter here.
(It’s in Spanish, but there’s a translation option at the top right of the menu)
Read the first edition here.
LAB+ in the Media:
Local
Radio Sarandí – Interview with Matías Machado about Scaffold Biotech’s cattle tick vaccine
El País – The five key features of the Uruguayan vaccine that could change the fight against ticks
Radio Sarandí – Carlos Batthyány talks about Lab+, the vaccine developed by Scaffold Biotech, and the drug from Eolo Pharma
InfoNegocios – A Uruguayan startup dedicated to early cancer diagnosis adds a former dLocal member as CEO
Forbes Uruguay – Interview with Carlos Batthyány about LAB+ and the Institut Pasteur de Montevideo
Búsqueda – International call for startups, interview with Carlos Batthyány and Paul Elberse
En Perspectiva – Agustín Correa and Matías Machado, from Scaffold Biotech: Uruguayan company works with protein engineering to reach a ‘new frontier in vaccination’
Modo País (Channel 5) – Guska, created by Pilar Moreno and Gonzalo Moratorio
En Perspectiva – Felipe Trajtenberg, from LoCBio: reprogramming bacteria to treat colorectal cancer
La Diaria – What do the first four start-ups of the LAB+ seek to develop?
Telemundo (Channel 12) – Scaffold Biotech: more efficient vaccines for animals
En Perspectiva – Director of the Institut Pasteur de Montevideo talks about the LAB+ iniciative and Gonzalo Moratorio explains the science behind the start-up Guska
Subrayado (Channel 10) – LAB+ closed its first financing cycle
Radio Carve – Director of the Institut Pasteur de Montevideo talks about LAB+
La Diaria – Conversations with the first four biotech start-ups funded by LAB+
El País (Business) – Institut Pasteur de Montevideo presented its first four start-ups
Uruguay XXI – Institut Pasteur de Montevideo presented its first four start-ups
Telenoche (Channel 4) – Juan Pablo Tosar talks about the start-up B4-RNA
Ambito – The Institut Pasteur will invest US$25M in Uruguayan start-ups
El Observador – Four start-ups from the Institut Pasteur de Montevideo obtained financing for US$ 5 million: which are they?
Telenoche (Channel 4) – Institut Pasteur de Montevideo presented its LAB+ Company Builder initiative
Montevideo Portal – The Institut Pasteur de Montevideo presents a program to support scientific-technological companies
International
El Ecosistema Startup – Scaffold Biotech’s tick vaccine
Infobae – Uruguayan scientists develop a vaccine against cattle tick
Yale Podcasts – Interview with Gonzalo Moratorio, Guska’s founder
Tekios – LAB+ international call for scientific projects and start-ups
SwissInfo – LAB+ international call for scientific projects and start-ups
Latin American Post – LAB+ pioneers a new era of scientific start-ups in Uruguay and beyond.
Infobae – Closing of first round of financing for LAB+.
EFE – The Institut Pasteur de Montevideo presents LAB+, with four start-ups.
Investing – The Institut Pasteur de Montevideo launches the LAB+ iniciative.
ABC (Paraguay) – With four start-ups, the Institut Pasteur de Montevideo launches the LAB+.
Bloomberg – New Venture Capital Fund Eyes Latin American Science Start-ups.
Bloomberg online – New venture capital fund sets its sights on Latin American scientific start-ups.
Perfil – A new venture capital fund targets Latin American science.
iProUP – Support for startups: Ficus Capital, biotech fund, looks for unicorns in Latin America.
Yahoo Finances – Biotech fund seeks unicorns in LatAm.